ISRG
Intuitive Surgical, Inc.
NASDAQ · Healthcare · Medical - Instruments & Supplies · US
$366.70
−0.85%Year over year
Reported trailing growth
- Revenue
- +20.7%
- EBITDA
- +34.5%
- EBIT
- +31.0%
- EPS
- +21.2%
- Free cash flow
- +61.6%
- Operating cash flow
- +31.1%
Forward estimates
Based on analyst estimates
- Revenue
- +13.1%
- EBITDA
- +21.8%
- EPS
- +27.9%
Three-year CAGR
- Revenue
- +17.4%
- EBITDA
- +26.5%
- EBIT
- +23.1%
- Net income
- +29.3%
- EPS
- +29.1%
- Free cash flow
- +37.5%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026